Posted on 9/10/18
Reliable Respiratory Earns The Joint Commission’s Gold Seal of Approval for Home Care Accreditation
NORWOOD, Mass.--(BUSINESS WIRE)--Reliable Respiratory, one of New England’s leading home respiratory and specialty medical equipment providers, today announced it has earned The Joint Commission’s Gold Seal . . .
Posted on 9/10/18
Boston Scientific To Acquire Augmenix For Prostate Tech
Boston Scientific (BSX) has announced an agreement to acquire Augmenix for up to $600 million in total consideration.
Posted on 9/10/18
Is Bristol-Myers Squibb Company a Buy?
Bristol-Myers Squibb (NYSE:BMY) stock has underperformed the S&P 500 index so far this year. It's also trailed well behind most of its peers, but it could . . .
Posted on 9/9/18
Parent Project Muscular Dystrophy and Sarepta Therapeutics Partner
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy(Duchenne), announced plans today to launch a patient- and physician-reported outcomes . . .
Posted on 9/9/18
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for . . .
Posted on 9/9/18
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to four new employees for an . . .
Posted on 9/7/18
Thermo Fisher To Buy Back $2B Of Stock
The board of Thermo Fisher Scientific (NYSE:TMO) has authorized the repurchase of $2B of its common stock. There is no expiration date for the buybacks.There is . . .
Posted on 9/7/18
Thermo Fisher To Acquire Advanced Bioprocessing Business From BD
Thermo Fisher Scientific (NYSE:TMO) to acquire Becton, Dickinson and Company's (NYSE:BDX) Advanced Bioprocessing business.This business combines a strong technical services program with a variety of peptones . . .
Posted on 9/7/18
AMAG Pharmaceuticals Pays Off $475 Million of Senior Secured Notes
WALTHAM, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it has redeemed $475 million of its outstanding 7.875% senior notes, . . .
Posted on 9/7/18
Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Company’s Board of Directors granted Dr. . . .
Posted on 9/6/18
Sage Therapeutics Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on September . . .
Posted on 9/6/18
UMB Healthcare Services and Bend Financial Partner
KANSAS CITY, Mo. & BOSTON--(BUSINESS WIRE)--UMB Healthcare Services, a division of UMB Bank, n.a., and Bend Financial today announced a partnership to offer UMB custodial account, . . .
Posted on 9/6/18
KalVista Pharmaceuticals Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease . . .
Posted on 9/6/18
BeiGene and SpringWorks Therapeutics Enter into Global Clinical Collaboration
CAMBRIDGE, Mass. & BEIJING & NEW YORK--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology . . .
Posted on 9/6/18
Here's Why Cara Therapeutics Rose 12.5% in August
What happenedShares of Cara Therapeutics (NASDAQ:CARA) jumped more than 12% in August, according to data from S&P Global Market Intelligence. The small-cap pharma company announced second-quarter . . .
Posted on 9/6/18
Here's Why Keryx Biopharmaceuticals Dropped 19.6% in August
What happenedShares of Keryx Biopharmaceuticals (NASDAQ:KERX) dropped nearly 20% last month, according to data from S&P Global Market Intelligence. The pharma company announced second-quarter and first-half . . .
Posted on 9/6/18
Here's Why AVEO Pharmaceuticals Inc. Jumped 40% Higher in August
What happenedShares of AVEO Pharmaceuticals (NASDAQ:AVEO) jumped 40% in August, according to data provided by S&P Global Market Intelligence as investors jump in ahead of data . . .
Posted on 9/6/18
AcuityBio and Cook Biotech Announce Agreements for Strategic Collaboration
NEWTON, Mass. & WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--AcuityBio Inc., a developer of novel drug-delivery, combination products, announced that it has entered into agreements with Cook Biotech Inc., . . .
Posted on 9/6/18
Dicerna Announces Proposed Follow-On Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the commencement of a proposed underwritten registered . . .
Posted on 9/6/18
KalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease . . .
Posted on 9/5/18
Serres Expands its Fluid Management Solutions
Serres Inc. is the U.S. division of Serres Oy, the progressive leader of smart fluid management solutions around suction for healthcare facilities. The company announced today . . .
Posted on 9/5/18
Fulcrum Therapeutics Announces $80 Million Series B Financing
Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies to unlock gene control and treat serious genetic diseases
Posted on 9/5/18
Checkmate Pharmaceuticals Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany and Pfizer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Checkmate Pharmaceuticals (Checkmate), announced that it has entered into a clinical trial collaboration and supply agreement with the alliance between Merck KGaA, Darmstadt, Germany, . . .
Posted on 9/5/18
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, . . .
Posted on 9/5/18
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon . . .

